Adrian H. Koh
About
In The Last Decade
Adrian H. Koh
17 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Ophthalmology 954
- Radiology, Nuclear Medicine and Imaging 631
- Molecular Biology 158
- Immunology 31
- Neurology 28
Countries citing papers authored by Adrian H. Koh
This map shows the geographic impact of Adrian H. Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian H. Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian H. Koh more than expected).
Fields of papers citing papers by Adrian H. Koh
This network shows the impact of papers produced by Adrian H. Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian H. Koh. The network helps show where Adrian H. Koh may publish in the future.
Co-authorship network of co-authors of Adrian H. Koh
This figure shows the co-authorship network connecting the top 25 collaborators of Adrian H. Koh. A scholar is included among the top collaborators of Adrian H. Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian H. Koh. Adrian H. Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | Visual and expanded anatomical outcomes for brolucizumab versus aflibercept in patients with neovascular AMD: 96-week data from HAWK and HARRIER | 4 |
| 5 | Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study | 2 |
| 6 | Polypoidal Choroidal Vasculopathy breakdown → | 255 |
| 7 | Ranibizumab treatment and visual acuity outcomes in the presence or absence of pigment epithelium detachments: an interim analysis of the LUMINOUS study | 1 |
| 8 | 88 | |
| 9 | 204 | |
| 10 | 13 | |
| 11 | 267 | |
| 12 | 91 | |
| 13 | 34 | |
| 14 | 8 | |
| 15 | 62 | |
| 16 | Effects of Long-term Atropine Usage on Retinal Function | 3 |
| 17 | 13 | |
| 18 | Anaemia--more than meets the eye. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.